- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.84 Å
- Oligo State
- homo-dimer
- Ligands
- 3 x SO4: SULFATE ION(Non-functional Binders)
- 2 x SAM: S-ADENOSYLMETHIONINE(Non-covalent)
SAM.2: 18 residues within 4Å:- Chain A: G.190, M.203, M.207, G.242, G.243, A.244, D.268, L.269, V.272, I.292, D.293, F.294, H.295, R.309, R.310, I.311, D.314
- Ligands: 76N.29
19 PLIP interactions:19 interactions with chain A- Hydrophobic interactions: A:A.244
- Hydrogen bonds: A:G.242, A:A.244, A:L.269, A:D.293, A:F.294, A:R.309
- Water bridges: A:T.188, A:G.190, A:T.248, A:T.248, A:R.309, A:R.310, A:D.314
- Salt bridges: A:H.216, A:R.309, A:R.310, A:D.314
- pi-Stacking: A:F.294
SAM.33: 12 residues within 4Å:- Chain B: G.242, A.244, D.268, L.269, I.292, D.293, F.294, H.295, R.309, R.310, I.311
- Ligands: EDO.39
9 PLIP interactions:9 interactions with chain B- Hydrophobic interactions: B:I.311
- Hydrogen bonds: B:G.242, B:A.244, B:D.293, B:F.294
- Water bridges: B:T.248, B:R.309
- Salt bridges: B:R.309
- pi-Stacking: B:F.294
- 33 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)
EDO.3: 3 residues within 4Å:- Chain A: R.71, L.74, H.75
Ligand excluded by PLIPEDO.4: 5 residues within 4Å:- Chain A: D.149, E.150, K.178, E.182, R.199
Ligand excluded by PLIPEDO.5: 7 residues within 4Å:- Chain A: E.37, Q.213, S.349, W.350, F.351, P.352
- Ligands: EDO.14
Ligand excluded by PLIPEDO.6: 5 residues within 4Å:- Chain A: Y.220, W.224, K.336, V.398
- Ligands: EDO.7
Ligand excluded by PLIPEDO.7: 5 residues within 4Å:- Chain A: T.384, G.385, H.387, V.398
- Ligands: EDO.6
Ligand excluded by PLIPEDO.8: 3 residues within 4Å:- Chain A: Q.277, R.285, L.289
Ligand excluded by PLIPEDO.9: 4 residues within 4Å:- Chain A: L.156, A.157, R.160
- Ligands: EDO.21
Ligand excluded by PLIPEDO.10: 6 residues within 4Å:- Chain A: K.245, W.247, Q.250, G.280, D.281, I.284
Ligand excluded by PLIPEDO.11: 5 residues within 4Å:- Chain A: Y.162, D.163, G.166, I.167
- Chain B: G.98
Ligand excluded by PLIPEDO.12: 3 residues within 4Å:- Chain A: K.77, E.80, K.81
Ligand excluded by PLIPEDO.13: 5 residues within 4Å:- Chain A: G.41, K.44, Q.45, W.350
- Ligands: EDO.14
Ligand excluded by PLIPEDO.14: 8 residues within 4Å:- Chain A: E.37, V.40, G.41, K.44, W.350
- Ligands: EDO.5, EDO.13, GOL.28
Ligand excluded by PLIPEDO.15: 5 residues within 4Å:- Chain A: E.191, S.194, R.195, S.270, G.271
Ligand excluded by PLIPEDO.16: 2 residues within 4Å:- Chain A: R.160, D.163
Ligand excluded by PLIPEDO.17: 3 residues within 4Å:- Chain A: T.128, A.129, R.132
Ligand excluded by PLIPEDO.18: 4 residues within 4Å:- Chain A: A.211, P.215, H.216, T.217
Ligand excluded by PLIPEDO.19: 1 residues within 4Å:- Chain A: Y.388
Ligand excluded by PLIPEDO.20: 4 residues within 4Å:- Chain A: R.373, I.383, T.384, G.385
Ligand excluded by PLIPEDO.21: 3 residues within 4Å:- Chain A: A.157, F.180
- Ligands: EDO.9
Ligand excluded by PLIPEDO.22: 2 residues within 4Å:- Chain A: G.183, S.184
Ligand excluded by PLIPEDO.23: 5 residues within 4Å:- Chain A: P.197, A.201, M.275, T.278, V.279
Ligand excluded by PLIPEDO.24: 3 residues within 4Å:- Chain A: G.136, V.137, N.138
Ligand excluded by PLIPEDO.34: 4 residues within 4Å:- Chain B: G.172, R.173, L.174, E.319
Ligand excluded by PLIPEDO.35: 3 residues within 4Å:- Chain B: R.71, L.74, H.75
Ligand excluded by PLIPEDO.36: 7 residues within 4Å:- Chain A: V.102, R.106, W.109
- Chain B: D.356, K.365, E.366, E.371
Ligand excluded by PLIPEDO.37: 3 residues within 4Å:- Chain B: L.289, M.290, A.291
Ligand excluded by PLIPEDO.38: 7 residues within 4Å:- Chain B: Y.161, E.169, P.170, T.171, G.172, L.174, H.175
Ligand excluded by PLIPEDO.39: 5 residues within 4Å:- Chain B: I.311, D.314, F.315
- Ligands: SO4.32, SAM.33
Ligand excluded by PLIPEDO.40: 7 residues within 4Å:- Chain B: D.149, E.150, P.153, V.154, K.178, T.181, E.182
Ligand excluded by PLIPEDO.41: 6 residues within 4Å:- Chain B: Y.151, K.178, V.189, M.193, M.203, I.362
Ligand excluded by PLIPEDO.42: 4 residues within 4Å:- Chain B: T.384, H.387, V.398
- Ligands: GOL.45
Ligand excluded by PLIPEDO.43: 4 residues within 4Å:- Chain A: T.31, P.33, H.36
- Chain B: R.54
Ligand excluded by PLIPEDO.44: 4 residues within 4Å:- Chain A: D.48, W.350
- Chain B: T.114, R.130
Ligand excluded by PLIP- 7 x GOL: GLYCEROL(Non-functional Binders)
GOL.25: 7 residues within 4Å:- Chain A: K.296, E.297, Q.298, Q.301, H.326, A.329, A.330
3 PLIP interactions:3 interactions with chain A- Hydrogen bonds: A:Q.298, A:Q.301, A:H.326
GOL.26: 5 residues within 4Å:- Chain A: D.149, E.150, E.198, R.199, N.202
7 PLIP interactions:7 interactions with chain A- Hydrogen bonds: A:R.71, A:D.149, A:D.149, A:E.150, A:E.150, A:E.198, A:N.202
GOL.27: 8 residues within 4Å:- Chain A: D.56, L.57, M.60
- Chain B: G.63, T.66, A.67, I.70, W.144
5 PLIP interactions:2 interactions with chain A, 3 interactions with chain B- Hydrogen bonds: A:D.56, A:M.60, B:G.63, B:A.67
- Water bridges: B:R.130
GOL.28: 9 residues within 4Å:- Chain A: E.37, K.44, S.212, Q.213, F.351
- Chain B: R.54, D.55, A.58
- Ligands: EDO.14
6 PLIP interactions:5 interactions with chain A, 1 interactions with chain B- Hydrogen bonds: A:E.37, A:K.44, A:S.212, A:S.212, A:Q.213
- Water bridges: B:R.54
GOL.45: 5 residues within 4Å:- Chain B: Y.220, W.224, K.336, V.398
- Ligands: EDO.42
No protein-ligand interaction detected (PLIP)GOL.46: 4 residues within 4Å:- Chain B: S.10, L.11, Q.45, A.49
3 PLIP interactions:3 interactions with chain B- Hydrogen bonds: B:L.11, B:Q.45
- Water bridges: B:D.12
GOL.47: 4 residues within 4Å:- Chain B: E.182, S.184, R.195, H.196
3 PLIP interactions:3 interactions with chain B- Hydrogen bonds: B:E.182, B:S.184, B:R.195
- 1 x 76N: 3-[[(1~{S},2~{R},4~{a}~{S},8~{a}~{S})-2-methyl-1,2,4~{a},5,6,7,8,8~{a}-octahydronaphthalen-1-yl]carbonyl]-5-[(1~{S},2~{R},5~{S},6~{S})-2,5-bis(oxidanyl)-7-oxabicyclo[4.1.0]heptan-2-yl]-4-oxidanyl-1~{H}-pyridin-2-one(Non-covalent)
76N.29: 17 residues within 4Å:- Chain A: W.143, M.146, G.147, Y.151, V.189, G.190, M.203, M.207, R.310, R.313, D.314, L.355, F.358, L.359, I.362
- Chain B: Q.61
- Ligands: SAM.2
16 PLIP interactions:16 interactions with chain A- Hydrophobic interactions: A:W.143, A:W.143, A:M.146, A:Y.151, A:Y.151, A:V.189, A:F.358, A:F.358, A:I.362
- Hydrogen bonds: A:R.310, A:R.313, A:D.314
- Water bridges: A:G.190, A:G.190, A:S.206, A:R.310
- 1 x 1PE: PENTAETHYLENE GLYCOL(Non-functional Binders)
- 2 x PEG: DI(HYDROXYETHYL)ETHER(Non-functional Binders)
PEG.48: 7 residues within 4Å:- Chain A: L.140, M.210, A.211, S.212
- Chain B: L.52, P.53, R.54
5 PLIP interactions:3 interactions with chain A, 2 interactions with chain B- Hydrogen bonds: A:M.210, A:A.211, A:S.212, B:R.54, B:R.54
PEG.49: 4 residues within 4Å:- Chain B: R.373, G.385, I.386, H.387
3 PLIP interactions:3 interactions with chain B- Hydrogen bonds: B:R.373, B:I.386, B:H.387
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Zhou, J. et al., The crystal structure of FinI in complex with SAM and fischerin. To Be Published
- Release Date
- 2023-02-15
- Peptides
- Methyltransf_2 domain-containing protein: AB
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
B
- Coordinates
- PDB Format
- Method
- X-RAY DIFFRACTION 1.84 Å
- Oligo State
- homo-dimer
- Ligands
- 3 x SO4: SULFATE ION(Non-functional Binders)
- 2 x SAM: S-ADENOSYLMETHIONINE(Non-covalent)
- 33 x EDO: 1,2-ETHANEDIOL(Non-functional Binders)
- 7 x GOL: GLYCEROL(Non-functional Binders)
- 1 x 76N: 3-[[(1~{S},2~{R},4~{a}~{S},8~{a}~{S})-2-methyl-1,2,4~{a},5,6,7,8,8~{a}-octahydronaphthalen-1-yl]carbonyl]-5-[(1~{S},2~{R},5~{S},6~{S})-2,5-bis(oxidanyl)-7-oxabicyclo[4.1.0]heptan-2-yl]-4-oxidanyl-1~{H}-pyridin-2-one(Non-covalent)
- 1 x 1PE: PENTAETHYLENE GLYCOL(Non-functional Binders)
- 2 x PEG: DI(HYDROXYETHYL)ETHER(Non-functional Binders)
- Links
- RCSB PDBe PDBe-KB PDBj PDBsum CATH PLIP
- Citation
- Zhou, J. et al., The crystal structure of FinI in complex with SAM and fischerin. To Be Published
- Release Date
- 2023-02-15
- Peptides
- Methyltransf_2 domain-containing protein: AB
- SMTL:PDB
- SMTL Chain Id:
PDB Chain Id:A
AB
B